Medical device threat modeling is a structured way to identify how a device, its software, its data, and its connected environment could be compromised or misused, then decide which risks need controls. Its value is not in producing a long list of attack names. Its value is in helping a team make defensible product decisions before a security issue becomes a safety, schedule, or support problem.
A connected device rarely exists alone. It may exchange information with a mobile app, cloud service, hospital network, programmer, service tool, manufacturing system, or third-party component. Each connection can create a way for information to move, a function to be changed, or an expected service to become unavailable. The team needs a practical view of those relationships before it can decide which protections matter.
Threat modeling gives that view a shared structure. It brings engineering, quality, clinical, service, and regulatory perspectives to the same set of questions: what must be protected, where could it be exposed, what could realistically happen, and how would the device remain safe? The U.S. Food and Drug Administration's current cybersecurity guidance for medical devices frames cybersecurity as part of device design, documentation, and quality system work. A useful threat model gives those records a common starting point.
Start With the Decisions the Model Must Support
Teams sometimes treat threat modeling as an exercise to complete because a reviewer may ask for it. That approach usually produces a generic worksheet that arrives after the architecture is largely fixed. A stronger starting point is to decide which product questions the model needs to answer.
For example, can the device remain safe when a network connection drops? Who can change a therapy setting or install a software update? What information is available through a service port? Can a user or technician distinguish a valid remote instruction from a malicious one? How will the manufacturer know whether an affected software component is present when a vulnerability is announced? These are concrete design and support questions, not abstract security labels.
A model does not need to predict every possible attack. It should identify the realistic misuse and compromise paths that matter for the device's intended use, users, operating environment, and clinical consequences. The result should give the team a record of decisions, open questions, owners, and assumptions that can be tested as development progresses.
Run a Focused Working Session Before Design Choices Harden
The first working session does not need to become an all-day security review. Bring together the people who understand the intended use, architecture, software, quality process, service model, and clinical workflow. Give them a current system sketch and ask each person to explain the interfaces, assumptions, and failure conditions they know best. The objective is not to reach perfect detail. It is to expose the decisions that should not be left implicit.
Begin with the intended users and use environment. A device used by trained hospital staff, a device used in a patient's home, and a device maintained by a distributor may face very different access, connectivity, and recovery conditions. Then walk through normal operation, setup, configuration, service, update, and retirement. For each step, identify what information or function crosses a boundary and what must happen if that step is disrupted, altered, or performed by the wrong person.
Finish with a short action list. Some questions will need technical investigation, some will become product requirements, and some may reveal a constraint on a planned feature. Record the assumption behind each decision and assign an owner. That simple discipline prevents a model from becoming a static diagram. It also gives leadership a practical view of which decisions affect timing, scope, evidence, or long-term support before the program is locked into a costly path.
Define the System Boundary Before Listing Threats
The most common weakness in a medical device threat model is a boundary that is too narrow. A device may look self-contained in a product photo while the real product system includes a clinician workstation, cloud infrastructure, software update service, manufacturing provisioning, diagnostic interface, and field service laptop. Ignoring those relationships does not remove the risk. It only makes the later analysis incomplete.
Start with a plain-language system map. Identify the device itself, the data it creates or receives, physical and wireless interfaces, external systems, user roles, remote support paths, manufacturing activities, and the actions that must work reliably for safe performance. Include the conditions that matter when a normal connection is unavailable. A home-use device, a hospital-connected monitor, and a serviceable surgical system can all have very different boundaries even when their technology stacks look similar.
The map should show where trust changes. A manufacturer-controlled update service, a hospital network, a patient-owned phone, and a technician's service tool should not all be treated as equally controlled environments. Naming those boundaries helps the team ask where authentication, authorization, validation, logging, or fail-safe behavior may be needed.
Identify What Needs Protection and Why
Once the boundary is clear, identify the assets that are important to safe and effective use. These may include therapy settings, alarm behavior, diagnostic outputs, patient-related data, calibration values, software images, cryptographic keys, service credentials, audit logs, and the device's ability to perform its core function. Asset does not only mean a file. Availability and correct operation can be just as important as confidentiality.
Next, describe what could happen to each asset. Could it be read by an unauthorized party, changed without approval, delayed, made unavailable, or substituted with a false input? Could a normal user be tricked into using a device in an unsafe state? Could a loss of communication make a clinician unable to see the information they expect? The practical focus is the consequence to the device, the workflow, and the people relying on it.
This is where cybersecurity and safety analysis need to stay connected. An unauthorized setting change may have an obvious safety consequence. A delayed diagnostic result may affect a clinical decision. A compromised service credential may create a pathway to install an unverified update. Other events may have limited clinical effect but still create an unacceptable privacy, operational, or support burden. The model should make the reasoning visible rather than assuming every event has the same importance.
Follow Plausible Attack Paths, Not Just a Checklist
A checklist can remind a team to consider common control areas, but it cannot replace reasoning about the actual product. For each meaningful asset and interface, ask how a person, process, or connected system could gain access, change information, interrupt a function, or bypass an intended safeguard. Then test whether that path is realistic in the device's environment.
Consider a device that accepts a field software update. A useful model would ask who creates the update, how the device verifies it, how authorization is granted, what happens if an update is interrupted, how a failed update is recovered, and what evidence proves the installed version is the intended one. A broad label such as "software update attack" is less useful unless it leads to those design and verification questions.
The NIST threat-modeling guidance is useful here because it emphasizes identifying the system, assets, threats, vulnerabilities, and mitigating controls in a repeatable way. The framework is not a substitute for device-specific judgment. It is a way to make sure the team can explain how it moved from a possible attack path to a proportionate decision.
Turn Threats Into Requirements and Testable Controls
A threat model earns its place in development when it changes what the team builds or verifies. Each significant scenario should lead to one or more decisions: a product requirement, architecture choice, risk control, process control, user-facing instruction, monitoring plan, or decision to accept a residual risk with a clear rationale. The connection should be traceable.
Controls may include authenticated access, role-based permissions, encryption, secure storage of credentials, signed software, secure boot, input validation, audit logging, network segmentation, timeouts, connection-loss behavior, or procedures for decommissioning equipment. The right control is the one that addresses a defined risk without creating an unacceptable usability or clinical burden. Adding controls because they sound sophisticated rarely produces a stronger product.
For a device used in an urgent clinical workflow, a control that prevents a needed action may itself create risk. For a home-use product, a complex credential process may encourage people to share access or avoid updates. The product team should consider clinical use, human factors, and security together. A secure design that people cannot use as intended does not provide the protection the model promised.
Connect the Model to Design Control Evidence
The threat model should not sit apart from the records that explain the product. It needs to align with the system architecture, intended use, cybersecurity requirements, risk management file, design reviews, verification plan, software component information, labeling, and post-market process. The more those records tell the same story, the easier it is for a team to find gaps before a submission or audit does.
A practical review traces a high-priority scenario from the interface that creates the exposure, through the control chosen, to the evidence showing that the control works. If a device requires signed updates, the design requirements should say so, verification should demonstrate it, and the maintenance process should define how updates are released and recovered. If a third-party component is important to the risk, the team should have a way to identify the deployed version and evaluate future vulnerability notices.
This is also where the broader quality system and regulatory strategy become essential. The evidence is easier to maintain when the people responsible for development, quality, clinical use, and regulatory submissions share the same record of the decisions behind it.
Update the Model When the Product Changes
Threat modeling is not a one-time design milestone. The model should be revisited when the device gains a new interface, connects to a different system, changes a software component, introduces remote support, changes its update approach, or moves into a new use environment. It should also inform post-market decisions when a vulnerability, complaint trend, or field observation raises a question about the assumptions made during development.
A manageable process does not require restarting from a blank page. It requires a clear trigger, a known owner, and a way to assess whether the change affects the model, risk analysis, controls, verification, labeling, or support procedures. This keeps cybersecurity work connected to the same change-control discipline that the rest of the device program needs.
How Qualira Helps Teams Make the Work Usable
A useful threat model must work for the people designing the device and the people who later need to review, verify, support, or defend it. Qualira helps medical-device teams connect cybersecurity decisions to intended use, product architecture, quality processes, clinical workflow, and submission readiness so the work leads to practical evidence instead of another isolated document.
Explore Qualira's integrated program approach or talk with the team when cybersecurity questions are slowing an important product decision.
Frequently asked questions
What is threat modeling for a medical device?
Threat modeling is a structured way to identify how a device, its software, its data, and its connected systems could be misused or compromised, then decide which risks need controls. For a medical device, the analysis must connect a security event to possible safety, performance, data, or availability consequences.
When should a medical-device team start threat modeling?
Start when the intended use, system boundary, and major architecture decisions are being defined. The model should then be updated as interfaces, software components, service tools, cloud features, and support plans become more specific. Starting early gives the team options before a design choice becomes expensive to change.
Is a threat model the same as risk management?
No. A threat model helps a team identify cybersecurity scenarios, attack paths, assets, and possible controls. Risk management evaluates the significance of those scenarios in the context of the device and its users. The two records should be connected, but they answer different questions.
What evidence should support a medical-device threat model?
The model should align with the system architecture, cybersecurity requirements, risk analysis, design decisions, verification results, software component information, labeling, and post-market maintenance procedures. A reviewer should be able to trace an important risk through the control and the evidence showing that the control works.
